Recombinant infectious bovine rhinotracheitis virus
US5593873A · kind A · utility
12Cited by
9References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 23, 1994 |
| Grant date | Jan 14, 1997 |
| Priority date | — |
| Expiry date | May 23, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18634
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides recombinant infectious bovine rhinotracheitis (IBR) viruses useful in vaccines to protect bovines from infectious bovine rhinotracheitis and other bovine diseases. The present invention further provides methods for distinguishing an animal vaccinated with the vaccine of the present invention from an animal infected with a naturally-occurring IBR virus. The present invention also provides isolated DNA encoding the gpE glycoprotein of IBR virus and isolated DNA encoding the gpG glycoprotein of IBR virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.